CSATM Test
Convenient blood test
– As a highly accurate and specific blood
test, CSATM overcomes deficiencies of the Pap smear. The CSATM may also be more
acceptable to women who avoid pelvic exams. Additionally, the CSATM
can be transported over great distances prior to testing and analysis does
not require highly trained personnel, including pathologists.
PSA-like – The CSATM test has advantages similar
to those of the Prostate Specific Antigen (PSA) test for men.
Diagnostic test –
The CSATM blood test identifies specific stages of the disease.
CSATM
is also available in a tissue-based form and can stage CIN and cervical
cancer.
Monitoring test –
Monitoring for recurrent disease is essential following treatment. CSATM decreases rapidly to
normal levels after successful treatment and increases as an early warning
signal of recurrent disease.
Metastasis test – Elevated
CSATM levels can be detected when cancer cells migrate from the
cervix. In the absence of active disease in the cervix, raised CSATM
can indicate the presence of otherwise undetected cancer of cervical origin
in other organs.
Screening test – Over one
hundred million women are tested annually by means of the Pap smear in the
developed world. This number could
be increased with an accurate blood test.
Proven assay –
Researchers at the Medical University of South Carolina (MUSC) discovered
the association between the CSATM molecule and cervical cancer,
publishing their data in prominent journals*.
CSATM levels
and interpretation
*Gynecological
Oncology (91: 486-493, 2003)
American
Journal of Reproductive Immunology
( 44: 114-120, 2000; 44:222-230, 2000 and 46:280-287, 2001)
